Literature DB >> 21478262

Complement dependency of cardiomyocyte release of mediators during sepsis.

Gelareh Atefi1, Firas S Zetoune, Todd J Herron, José Jalife, Markus Bosmann, Rami Al-Aref, J Vidya Sarma, Peter A Ward.   

Abstract

We have recently shown that antibody-induced blockade of C5a, C5a receptors, or IL-17A greatly reduced the harmful outcomes of sepsis. In the current study, normal cardiomyocytes from young (300 g) male Sprague-Dawley rats responded in vitro to C5a (ED(50)=55 nM) with release of IL-6 and TNFα, peaking between 2 to 8 h. Neutralizing antibodies to mouse C5a or IL-17A (ED(50)=40 μg for each, based on improved survival) reduced spontaneous in vitro release of cardiosuppressive cytokines and chemokines in cardiomyocytes obtained from mice with polymicrobial sepsis. A non-neutralizing C5a antibody had no such effects. Cardiomyocytes from septic mice (C57Bl/6) showed increased mRNA for TNFR1, IL-6 (gp80), and C5aR at 6 h after sepsis. Cardiomyocytes from septic C5aR(-/-) or C5L2(-/-) mice did not show spontaneous in vitro release of cytokines and chemokines. These data suggest that cardiomyocytes from septic mice release suppressive cytokines in a C5a-, C5aR-, and IL-17A-dependent manner, followed by mediator reactivity with receptors on cardiomyocytes, resulting in defective contractility and relaxation. These data may be relevant to a strategy for the treatment of heart dysfunction developing during sepsis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21478262      PMCID: PMC3114524          DOI: 10.1096/fj.11-183236

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  30 in total

1.  Cytokine profile of human septic shock serum inducing cardiomyocyte contractile dysfunction.

Authors:  O Joulin; P Petillot; M Labalette; S Lancel; R Neviere
Journal:  Physiol Res       Date:  2006-06-22       Impact factor: 1.881

2.  Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function.

Authors:  B S Cain; D R Meldrum; C A Dinarello; X Meng; K S Joo; A Banerjee; A H Harken
Journal:  Crit Care Med       Date:  1999-07       Impact factor: 7.598

3.  Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart.

Authors:  Madhu V Singh; Ann Kapoun; Linda Higgins; William Kutschke; Joshua M Thurman; Rong Zhang; Minati Singh; Jinying Yang; Xiaoqun Guan; John S Lowe; Robert M Weiss; Kathy Zimmermann; Fiona E Yull; Timothy S Blackwell; Peter J Mohler; Mark E Anderson
Journal:  J Clin Invest       Date:  2009-03-09       Impact factor: 14.808

4.  Association between mitochondrial dysfunction and severity and outcome of septic shock.

Authors:  David Brealey; Michael Brand; Iain Hargreaves; Simon Heales; John Land; Ryszard Smolenski; Nathan A Davies; Chris E Cooper; Mervyn Singer
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

5.  Potential role of poly(adenosine 5'-diphosphate-ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock.

Authors:  Francisco G Soriano; Antonio C Nogueira; Elia G Caldini; Marcelo H Lins; Ana C Teixeira; Sylas B Cappi; Paulo A Lotufo; Márcia M S Bernik; Zsuzsanna Zsengellér; Min Chen; Csaba Szabó
Journal:  Crit Care Med       Date:  2006-04       Impact factor: 7.598

6.  Immunodesign of experimental sepsis by cecal ligation and puncture.

Authors:  Daniel Rittirsch; Markus S Huber-Lang; Michael A Flierl; Peter A Ward
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

7.  Calcium-independent negative inotropy by beta-myosin heavy chain gene transfer in cardiac myocytes.

Authors:  Todd J Herron; Rene Vandenboom; Ekaterina Fomicheva; Lakshmi Mundada; Terri Edwards; Joseph M Metzger
Journal:  Circ Res       Date:  2007-03-15       Impact factor: 17.367

Review 8.  Molecular events in the cardiomyopathy of sepsis.

Authors:  Michael A Flierl; Daniel Rittirsch; Markus S Huber-Lang; J Vidya Sarma; Peter A Ward
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

9.  An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.

Authors:  Andreas D Niederbichler; Laszlo M Hoesel; Margaret V Westfall; Hongwei Gao; Kyros R Ipaktchi; Lei Sun; Firas S Zetoune; Grace L Su; Saman Arbabi; J Vidya Sarma; Stewart C Wang; Mark R Hemmila; Peter A Ward
Journal:  J Exp Med       Date:  2005-12-27       Impact factor: 14.307

10.  Adverse functions of IL-17A in experimental sepsis.

Authors:  Michael A Flierl; Daniel Rittirsch; Hongwei Gao; Laszlo M Hoesel; Brian A Nadeau; Danielle E Day; Firas S Zetoune; J Vidya Sarma; Markus S Huber-Lang; James L M Ferrara; Peter A Ward
Journal:  FASEB J       Date:  2008-02-25       Impact factor: 5.834

View more
  26 in total

1.  Evidence for anti-inflammatory effects of C5a on the innate IL-17A/IL-23 axis.

Authors:  Markus Bosmann; J Vidya Sarma; Gelareh Atefi; Firas S Zetoune; Peter A Ward
Journal:  FASEB J       Date:  2011-12-27       Impact factor: 5.191

2.  Cholinergic activation suppresses palmitate-induced macrophage activation and improves acylation stimulating protein resistance in co-cultured adipocytes.

Authors:  Jing Wu; Zhou-Yang Jiao; Rui-Zhen Li; Hui-Ling Lu; Hao-Hao Zhang; Katherine Cianflone
Journal:  Exp Biol Med (Maywood)       Date:  2017-03-20

3.  MyD88-dependent production of IL-17F is modulated by the anaphylatoxin C5a via the Akt signaling pathway.

Authors:  Markus Bosmann; Vinay R Patel; Norman F Russkamp; Florence Pache; Firas S Zetoune; J Vidya Sarma; Peter A Ward
Journal:  FASEB J       Date:  2011-08-22       Impact factor: 5.191

4.  Loss of duplexmiR-223 (5p and 3p) aggravates myocardial depression and mortality in polymicrobial sepsis.

Authors:  Xiaohong Wang; Wei Huang; Yang Yang; Yigang Wang; Tianqing Peng; Jiang Chang; Charles C Caldwell; Basilia Zingarelli; Guo-Chang Fan
Journal:  Biochim Biophys Acta       Date:  2014-01-29

5.  Comparative effects of parent and heated cinnamaldehyde on the function of human iPSC-derived cardiac myocytes.

Authors:  Matthew A Nystoriak; Peter J Kilfoil; Pawel K Lorkiewicz; Bhargav Ramesh; Philip J Kuehl; Jacob McDonald; Aruni Bhatnagar; Daniel J Conklin
Journal:  Toxicol In Vitro       Date:  2019-09-10       Impact factor: 3.500

Review 6.  Role of complement C5a and histones in septic cardiomyopathy.

Authors:  Fatemeh Fattahi; Lynn M Frydrych; Guowu Bian; Miriam Kalbitz; Todd J Herron; Elizabeth A Malan; Matthew J Delano; Peter A Ward
Journal:  Mol Immunol       Date:  2018-06-18       Impact factor: 4.407

7.  Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of Escherichia coli sepsis.

Authors:  Ravi Shankar Keshari; Robert Silasi; Narcis Ioan Popescu; Maulin Mukeshchandra Patel; Hala Chaaban; Cristina Lupu; K Mark Coggeshall; Tom Eirik Mollnes; Steven J DeMarco; Florea Lupu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-18       Impact factor: 11.205

8.  Complement Destabilizes Cardiomyocyte Function In Vivo after Polymicrobial Sepsis and In Vitro.

Authors:  Miriam Kalbitz; Fatemeh Fattahi; Todd J Herron; Jamison J Grailer; Lawrence Jajou; Hope Lu; Markus Huber-Lang; Firas S Zetoune; J Vidya Sarma; Sharlene M Day; Mark W Russell; José Jalife; Peter A Ward
Journal:  J Immunol       Date:  2016-08-12       Impact factor: 5.422

9.  The Cardiomyocyte as a Source of Cytokines in Cardiac Injury.

Authors:  Toshinori Aoyagi; Takashi Matsui
Journal:  J Cell Sci Ther       Date:  2011-12-01

10.  Complement-induced activation of the cardiac NLRP3 inflammasome in sepsis.

Authors:  Miriam Kalbitz; Fatemeh Fattahi; Jamison J Grailer; Lawrence Jajou; Elizabeth A Malan; Firas S Zetoune; Markus Huber-Lang; Mark W Russell; Peter A Ward
Journal:  FASEB J       Date:  2016-08-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.